Consultancy firm IDEA Pharma has released what it calls a ‘Productive Innovation Index’, which ranks pharmaceutical companies based on their ability to successfully commercialize new innovations.
The European Commission claims that Johnson & Johnson and Novartis may have breached European antitrust rules.
GlaxoSmithKline has entered into an agreement to purchase Shenzhen Neptunus? stake in a previously formed joint venture between the companies involved in the development and manufacture of influenza vaccines in China, Hong Kong, and Macau.
A European pilot initiative will test the impact of consultations with a number of stakeholders such as patient representatives and payers on early stage drug development.
August 20, 2010.